Synchronous Bilateral Talc Pleurodesis

N/ACompletedNCT07810049

European Institute of Oncology31 enrolled

Overview

Investigate feasibility of synchronous bilateral talc pleurodesis for malignant bilateral pleural effusions

Study Type

OBSERVATIONAL

Enrollment

Conditions

Bilateral Pleural Effusion Pleurodesis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age ≥ 18 year-old * Patients undergoing synchronous bilateral talc pleurodesis * Diagnosis of malignant bilateral pleural effusions * Surgical resection between 1998 and September 2025 Exclusion Criteria: * Other type of surgery * Lack of consent to research * Other type of diagnosis (e.g. viral disease)

Locations (1)

Istituto Europeo di Oncologia

Milan, Italy

Outcomes

Primary Outcomes

postoperative mortality

Evaluation of postoperative complications occurred after talc pleurodesis.

Time frame: 35 years

postoperative morbidity

Evaluation of postoperative complications occurred after talc pleurodesis.

Time frame: 35 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.